In recent years, several health plans in the Health Insurance Marketplace exchange were offering free doctors’ visits to their members, with the hope of identifying illnesses before they become more difficult or more expensive to treat.
Patients’ Choice for Site of Care Motivated by More Than Cost Alone
Rheumatoid arthritis (RA) is the most common autoimmune inflammatory arthritis in adults, with a prevalence of approximately 0.6% in the United States. RA has a significant negative impact on health-related quality of life and imposes a substantial economic burden on the US healthcare system.
Identifying the Most Clinically and Economically Effective Therapies for Rheumatoid Arthritis Remains a Challenge for Providers and Payers
Rheumatoid arthritis (RA) is a chronic inflammatory disease that is typically accompanied by swelling, tenderness of the joints, and destruction of the synovial joints. The progression of RA can cause disability and can have serious physical, mental, and economic consequences for patients.
Understanding Patients’ Demographics Is Key to Improving Clinical and Economic Healthcare Outcomes
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease of unknown cause that primarily affects the peripheral joints in a symmetric pattern. RA’s effect on other areas of the body, including the skin, heart, lungs, and eyes, can be substantial.
Rheumatoid Arthritis, Biologic Drugs, and Associated Cost

The healthcare system in the United States is evolving as a result of the increasing availability of real-world data and the influence of value-based policy and quality initiatives.

Hypothesis Generation: An Essential Component of Informed Healthcare Management

Prostate cancer is the second most common invasive cancer diagnosed among men worldwide, and the most common cancer diagnosed in developed regions of the world, with an estimated age-standardized rate of 63 cases per 100,000 person-years.

Molecular Tests May Aid Clinical Decision-Making and Reduce Healthcare Costs

Multiple sclerosis (MS) is a chronic, debilitating disease that attacks the central nervous system. It is estimated that approximately 400,000 people are living with MS in the United States, and approximately 10,400 patients are newly diagnosed with the disease annually.

What Makes Specialty Pharmacy Care So Special?
Prior authorization (PA) is a technique that is frequently implemented by managed care organizations to manage the utilization of expensive drugs and to improve the precision of drug prescribing.
The growing number of partnerships between hospitals, outpatient care providers, and academic medical centers has been attributed, at least in part, to the healthcare reform initiated by the Affordable Care Act (ACA), which rewards hospitals for improving patient health outcomes and reducing healthcare costs.
Measurable Clarity in Healthcare Is Needed So Those Who Use the System Could Achieve a State of Well-Being
Malignant melanoma is the sixth most often diagnosed cancer in the US. With new treatment options, here is an examination of costs associated with treating adverse events with various therapies.
Reducing Adverse Events and Healthcare Resource Waste by Careful Selection of the Best Drug Therapy
Page 2 of 12
Results 11 - 20 of 111
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME